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We present the case of a 35-year-old patient who was found to be aﬀected by an isolated clinically silent cardiac metastasis
despite a negative CT follow-up at one year from abdominal surgery for colorectal cancer. CT/PET and tumor marker GICA
were fundamental in suggesting the diagnosis, which was then conﬁrmed by cardiac magnetic resonance and surgical biopsy. This
is a very rare modality of presentation of cardiac metastasis because of the young age of our patient and the absence of disease in
other sites.
1.Introduction
Colorectal cancer is the third most commonly diagnosed
cancer in males and the second in females with over 1,2
million new cancer cases and 608,700 deaths estimated to
have occurred in 2008. Metastases from colorectal cancer can
occur either by lymphatic or hematogenous spreading, and
the sites most commonly involved are lymph nodes, liver,
and lung. Unusual sites such as the spleen, thyroid gland,
spermatic cord, and skeletal muscle have been reported
as a distinctive feature of end-stage disease [1]. Cardiac
metastasization from colorectal cancer is an extremely rare
event and occurs either with the concomitant involvement
of other organs or, more rarely, as the only localization. We
report the case of a 35-year-old man who was found to
be aﬀected by an isolated clinically silent cardiac metastasis
despite a negative CT follow-up at one year from abdominal
surgery for colorectal cancer.
2. Case Presentation
A progressive increase of tumor marker GICA (180U/mL)
was detected in an asymptomatic 35-year-old patient with
a history of metastatic colorectal cancer, despite a negative
CT follow-up at one year from abdominal surgery. He had
been treated with right hemicolectomy and liver metasta-
sectomy followed by adjuvant chemotherapy with FOLFIRI
(leucovorin, ﬂuorouracil, and irinotecan) plus bevacizumab.
Positron emission tomography/computed tomography
(PET/CT), performed for restaging purpose, revealed the
presence of a right angle cardiophrenic marked uptake
(Figure 1). A cardiac magnetic resonance (CMR) study was
performed to characterize this ﬁnding. CMR conﬁrmed the
presence of a solid mass (50 × 64 × 26mm) inside the
visceral paper of the pericardium and inﬁltrating the basal
wall of the right ventricle (Figures 2(a) and 2(b)); this mass
was characterized by a moderate hyperintensity on T2w
images (Figure 2(c)) and by a progressive ring enhancement
(Figure 2(d)) and was interpreted as a probable secondary
malignant lesion. So the patient underwent cardiac surgery
in order to obtain a histologic diagnosis of the ventricular
mass and for debulking purpose. Surgical biopsy conﬁrmed
the secondary nature of the cardiac lesion histologically cor-
responding to a moderately diﬀerentiated adenocarcinoma,
reported to be colorectal secondary malignancy, invading
the sierosa with lymphovascular and perineural invasion.2 Case Reports in Medicine
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Figure 1: Positron emission tomography/computed tomography (PET/CT) with (18)F-ﬂuoro-2-deoxyglucose showed an intense tracer
uptake localized at the right cardiofrenic angle, as shown in transaxial and sagittal views ((b) and (a), resp.).
Figure 2: Short-axis diastolic (a) and systolic (b) phase clearly showing the large solid mass anteriorly to the right ventricle. (c) Short-axis
T2w black-blood image easily depicting the hyperintense mass that largely inﬁltrates the myocardium of right ventricular wall which is
thinned or completely undistinguishable from the pathological tissue. (d) Short-axis late gadolinium image showing the progressive ring
enhancement of the lesion (arrow head), which was interpreted as a probable secondary malignant lesion.Case Reports in Medicine 3
Unfortunately, debulking surgery could not be performed
without sacriﬁcing the tricuspid valve, since the metastasis
deeply inﬁltrated it. Atrioventricular sulcus was aﬀected by
disease, as well.
The patient was then treated with FOLFOX-6 (leucov-
orin, ﬂuorouracil, and oxaliplatin) chemotherapy regimen
with poor results and, few months later, developed pericar-
dial eﬀusion, congestive heart failure, and syncopal attacks.
Eventually,hediedduetotheobstructionofrightventricular
outﬂow tract.
3. Discussion
Cardiac tumors are a peculiar subdivision of oncology. Al-
thoughtheyareclassiﬁedaseitherprimary(benignormalig-
nant) or secondary, we still lack a deﬁnitive classiﬁcation
based on aetiology, histopathology, or a system of staging
for the tumors of the heart. Primary tumors of the heart
are mostly myxomas whereas cardiac metastases result from
lung, lymphoreticular, breast, and colon malignancies [2].
The incidence of cardiac metastases is probably under-
estimated. This is partly justiﬁed by the very low impact
expected or because they are clinically silent in most cases.
Indeed, few similar case reports [1, 3, 4]h a v eb e e na l r e a d y
documented. However, according to the literature, cardiac
metastases have been found in 1,5%–20% of autopsies of
cancer patients and in 0,2%–6,5% of subjects in unselected
autopsy series [5, 6]. So why is the problem so underesti-
mated in clinical practice? Is it possible that the incidence of
cardiacmetastasesisreallysolow?Thisunderestimationmay
be due to the inadequacy of routinely performed diagnostic
modalities. In our case, CT scan alone could not reveal the
presence of the pathological cardiac tissue, and the choice to
perform a PET/CT and CMR, which easily identiﬁed it, was
driven by the increase of tumor marker GICA. Nevertheless
our patient turned out to be already beyond operability. For
thisreason,amoreeﬀectiveinstrumentalfollow-upmightbe
necessaryatleastforselectedcategories,suchasyoungcancer
patients with tumors known to frequently involve the heart,
in order to early detect cardiac metastases. In such a context,
treatment, although not curative, may lead to prolonged life
expectancy and improved quality of life, which are valuable
goals in this kind of patients.
There is not a standardized approach or treatment for
patients with cardiac metastases because of the lack of
randomized clinical trials, as well. So patients should be
treated according to the established rules of the involved
tumor [7].
However, several reports underline the role of surgery as
the therapy of choice, as compared to chemotherapy; Mur-
phy et al. performed operations on 19 patients with cardiac
metastases and reported an operative survival of 68,4%, with
asigniﬁcantimprovementofqualityoflifeandprolongedlife
expectancy (5 patients had an average survival of 3.2 years)
[8], as conﬁrmed by other reports [3, 4].
In our case, since the patient was inoperable, chemother-
apy was the only option we considered, but, unfortunately,
he did not respond and died few months later.
So, despite the poor prognosis of patients with cardiac
metastases, surgery, although not curative, should be pre-
ferred as compared to chemotherapy, especially in patients
withlocalizeddiseaseorinpresenceofsymptomsofobstruc-
tion.
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